Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of S-1 in Digestive Organ Cancer
NCT00197431Phase 2Unknown
- Sponsor
- Hamamatsu University School of Medicine
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in gastric cancer (GC), esophageal cancer, pancreatic cancer (PC) and 1 more, sponsored by Hamamatsu University School of Medicine. Primary endpoint: Influence of CYP2A6 and DPD activity on PK/PD of S-1 and clinical outcomes. Status: unknown.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)esophageal cancerpancreatic cancer (PC)colon cancer
Beyond the preview
Go deeper on NCT00197431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197431.